SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ARAY

Accuray Inc (NASDAQ:ARAY)

US · Delayed Price · Currency is USD
Also listed: 0H8I.LHealthcare · Medical - Devices
$2.08-$0.04 (-2.12%)
 
Market cap
$6.22M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 8, 2007
Market Cap$6.22M-94.9%
Revenue (ttm)$394.53M-12.5%
Net Income-$17.38M+10.0%
EPS-$5.82+7.9%
Shares Out3.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume111,533
Open$2.18
Previous Close$2.12
Day's Range$2.04 - $2.19
52-Week Range$2.04 - $45.20
Beta1.38
AnalystsBuy
Price Target$2.00(-3.61%)
Earnings DateFeb 3, 2027
-2.36% (1D)
No price history available.

About ARAY

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

Address
1240 Deming Way, Madison, WI, 53717-1954, US
Market Cap
6 million
Employees
809
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$134.68K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From ARAY’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.12%
5 Days
-24.55%
1 Month
-61.29%
6 Months
-83.10%
1 Year
-94.86%

$ARAY stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ARAY holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ARAY's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ARAY Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ARAY Revenue by Segment or Geography

ARAY's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New ARAY patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ARAY from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ARAY

VTIVanguard Morningstar Total Stock Market ETF$344.49K
VXFVanguard Extended Market ETF$172.96K
FESMFidelity Enhanced Small Cap ETF$80.03K
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF$20.66K
MSSMMorgan Stanley Pathway Funds - Small-Mid Cap Equity ETF$6.42K
PRFZInvesco RAFI US 1500 Small-Mid ETF$6.10K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ARAY’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
20.92
Analyst Ratings
40% of score
49
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$134.68K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.16%
STSBiShares Factors US Small Blend Style ETF0.07%

Weight is the stock’s share of each fund’s holdings.